The global antiviral drugs market, valued at USD 49.6 billion in 2022, is expected to witness steady growth, reaching USD 66.53 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 3.74% during the forecast period from 2023 to 2030. The rising prevalence of viral infections, coupled with advancements in drug development technologies, is fueling the growth of the antiviral drugs...